In contrast, the hypermethylation of the MLH1 promoter has been associated with decreased MLH1 expression and DNA repair capacity in cancer cells, which can increase the accumulation of somatic mutation in cancer cells and induce drug resistance.208. This evidence concerns the gene MLH1 and cancer.